Heterocyclic amines: Evaluation of their role in diet associated human cancer

British Journal of Clinical Pharmacology

Volumn 42, Issue 1, 1996, Pages 91-98

  Gooderham, N J ^a   Murray, S ^a   Lynch, A M ^a   Edwards, R J ^a   Yadollahi Farsani, M ^a   Bratt, C ^a   Rich, K J ^a   Zhao, K ^a   Murray, B P ^a   Bhadresa, S ^a   Crosbie, S J ^a   Boobis, A R ^a   Davies, D S ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Bioavailability; Carcinogenicity; CYP1A2; DiMeIQx; Heterocyclic amines; MeIQx; Metabolism; Mutagenicity; PhIP

Indexed keywords

CYTOCHROME P450 ISOENZYME; HETEROCYCLIC AMINE;

CARCINOGENICITY; CATALYSIS; CONFERENCE PAPER; DIET; HAMSTER; HUMAN; HYDROXYLATION; METABOLISM; MOUSE; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RODENT;

EID: 8944241771     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1996.37513.x     Document Type: Conference Paper

References (56)

1. Doll R, Peto R. The Causes of Cancer. Oxford Medical Publications, Oxford University Press, Oxford. 1981; 1226-1235.
2. Williams GM. Food and Cancer. Nutr International 1985; 1: 49-59.
3. Doll R. The lessons of life: Keynote address to the Nutrition and Cancer conference. Cancer Res. [suppl.] 1992; 52: 2024s-2029s.
4. Wakabayashi K, Sugimura T, Nagao M. Mutagens in Foods. In Genetic toxicology, eds Li AP, Heflich RH. CRC Press, Boca Raton, 1991; 303-338.
5. Sugimura T and Sato S. Mutagens - Carcinogens in foods. Cancer Res [Suppl.] 1983; 43: 2415s-2421s.
6. Sugimura T, Nagao M, Kawachi T, et al. Mutagen-carcinogens in food, with special reference to highly mutagenic pyrolytic products in broiled foods. In Origins of human cancer eds Hiatt HH. Watson JD, Winsten JA. Cold Spring Harbour, NY: Cold Spring Harbour Laboratory, 1977; 1561-1577.
7. Commoner B, Vithayathil AJ, Dolara P, Nair S, Madyastha P, Cuca GC. Formation of mutagens in beef and beef extract during cooking. Science 1978; 201: 913-916.
8. Skog K. Cooking procedures and food mutagens: a literature review. Fd Chem Toxic 1993; 31: 655-675.
9. Felton JS, Knize MG, Shen NH, Andresen BD, Bjeldanes LF, Hatch FT. Identification of the mutagens in cooked beef. Environ Health Persp 1986; 67: 17-24.
10. Murray S, Gooderham NJ, Barnes VF, Boobis AR, Davies DS. Trp-P-2 is not detectable in cooked meat and fish. Carcinogenesis 1987; 8: 937-940.
11. Murray S, Gooderham NJ, Boobis AR, Davies DS. Measurement of MeIQx and DiMeIQx in fried beef by capillary column gas chromatography electron capture negative ion chemical ionisation mass spectrometry. Carcinogenesis 1988; 9; 321-325.
12. Murray S, Lynch AM, Knize MG, Gooderham NJ. Quantification of the carcinogens 2-amino-3,8-dimethyl-and 2-amino-3,4,8-trimethylimidazo[4,5-f]quinoxaline and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in food using a combined assay based on gas chromatography-negative ion mass spectrometry. J Chromatogr 1993; 616: 211-219.
13. Jagerstad M, Laser Reutersward A, Oste R, et al. Creatine and Maillard reaction products as precursors of mutagenic compounds formed in fried beef. The Maillard Reaction in Foods and Nutrition. eds Waller G, Feather M. Washington DC, 1983: 507-519.
14. Jagerstad M, Skog K, Grivas S, Olsson K. Formation of heterocyclic amines using model systems. Mutat Res 1991; 259: 219-233.
15. Skog K, Knize MG, Felton JS, Jagerstad M. Formation of new heterocyclic amine mutagens by heating creatinine, alanine, threonine and glucose. Mutat Res 1992; 268: 191-197.
16. Gooderham NJ, Watson D, Rice JC, Murray S, Taylor GW, Davies DS. Metabolism of the mutagen MeIQx in vivo: metabolite screening by liquid chromatography-thermospray mass spectrometry. Biochem Biophys Res Commun 1987; 148: 1377-1382.
17. 14C]amino-3,8-dimethylimidazo[4,5-f]quinoxaline in mice. Analysis by whole animal autoradiography. Hum Exp Toxicol 1991; 10: 337-345.
18. Murray S, Gooderham NJ, Boobis AR, Davies DS. Detection and measurement of MeIQx in human urine after ingestion of a cooked meat meal. Carcinogenesis 1989; 10: 763-765.
19. Boobis AR, Lynch AM, Murray S et al. CYP1A2 catalysed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans. Cancer Res 1994; 54: 89-94.
20. Lynch AM, Knize MG, Boobis AR, Gooderham NJ, Davies DS, Murray S. Intra- and inter-individual variability in systemic exposure in man to MeIQx and PhIP, carcinogens present in cooked beef. Cancer Res 1992; 52: 6216-6223.
21. Watkins BE, Susuki M, Wallin H, et al. The effect of dose and enzyme inducers on the metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rats. Carcinogenesis 1991; 12: 2291-2295.
22. Turesky RJ, Markovic J, Bracco-Hammer I, Fay LB. The effect of dose and cytochrome P450 induction on the metabolism and disposition of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in the rat. Carcinogenesis 1991; 12: 1847-1855.
23. Sjodin P, Wallin H, Alexander J, Jagerstad M. Disposition and metabolism of the food mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in rats. Carcinogenesis 1989; 10: 1269-1275.
24. Turesky RJ, Aeschbacher HU, Wurzner HP, Skipper PL, Tannenbaum SR. Major routes of metabolism of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-/] quinoxaline in the rat. Carcinogenesis 1988; 9: 1043-1048.
25. Turteltaub KW, Knize MG, Healy SK, Tucker JD, Felton JS. The metabolic disposition of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the induced mouse. Food Chem Toxicol 1989; 27: 667-673.
26. Watkins BE, Esumi H, Wakabayashi K, Nagao M, Sugimura T. Fate and distribution of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rats. Carcinogenesis 1991; 12: 1073-1078.
27. Rich K, Murray BP, Lewis I, Rendell N, Davies DS, Gooderham NJ, Boobis AR. N-Hydroxy-MeIQx is the major microsomal oxidation product of the dietary carcinogen MeIQx with human liver. Carcinogenesis 1992; 13: 2221-2226.
28. Zhao K, Murray S, Davies DS, Boobis AR, Gooderham NJ. Metabolism of the food derived mutagen and carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) by human liver microsomes. Carcinogenesis 1994; 15: 1285-1288.
29. Murray BP, Boobis AR, de la Torre R, Segura J, Davies DS. Inhibition of dietary mutagen activation by methylxanthines. Biochem Soc Transact 1988; 12: 620-621.
30. Murray BP, Edwards RJ, Murray S, Singleton AM, Davies DS, Boobis AR. Human hepatic CYPIA1 and CYPIA2 content, determined with specific anti-peptide antibodies, correlates with the mutagenic activation of PhIP. Carcinogenesis 1993; 14: 585-592.
31. Sesardic D, Boobis AR, Murray BP, et al. Furafylline is a potent and selective inhibitor of cytochrome P4501A2 in man. Br J Clin Pharmacol 1990; 29: 651-663.
32. Thompson LH, Tucker JD, Stewart SA, et al. Genotoxicity of compounds from cooked beef in repair-deficient CHO cells versus Salmonella mutagenicity. Mutagenesis 1987; 2: 483-487.
33. Winton DJ, Gooderham NJ, Boobis AR, Davies DS, Ponder BAJ. The putative dietary carcinogen MeIQx is not mutagenic in mouse intestine in vivo as determined by the D1b-1 specific locus test. Cancer Res 1990; 50: 7992-7996.
34. Brooks RA, Gooderham NJ, Zhao K, et al. 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine is a potent mutagen in the mouse small intestine. Cancer Res 1994; 54: 1665-1667.
35. Buonarati MH, Turtletaub KW, Shen NH, Felton JR. Role of sulphation and acetylation in the activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine to intermediates which bind to DNA. Mutat Res 1990; 245: 185-190.
36. Turesky RJ, Rossi SC, Welti DH, Lay JO Jr, Kadlubar FF. Characterization of DNA adducts formed in vitro by reaction of N-hydroxy-2-amino-3-methylimidazo[4,5-f] quinoline and N-hydroxy-2-amino-3,8-dimethylimidazo [4,5-f]lquinoxaline at the C-8 and N2 atoms of guanine. Chem Res Toxicol 1992; 5: 479-490.
37. Frandsen H, Grivas S, Andersson R, Dragsted L, Larsen JC. Reaction of the N2-acetoxy derivative of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) with 2′-deoxyguanosine and DNA. Synthesis and identification of N2-(2′-deoxyguanosin-8-yl)-PhIP. Carcinogenesis 1992; 13: 629-635.
38. Lin D, Kaderlik KR, Turesky RJ, Miller DW, Lay JO, Kadlubar FF. Identification of N-[deoxyguanosin-8-yl]-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine as the major adduct formed by the food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, with DNA. Chem Res Toxicol 1992; 5: 691-697.
39. Wölfel C, Heinrich-Hirsch B, Schulz-Schalge T, et al. Genetically engineered V79 Chinese hamster cells for stable expression of human cytochrome P450IA2. Eur J Pharmacol 1992; 228: 95-102.
40. Yadollahi-Farsani M, Gooderham NJ, Doehmer J, Davies DS, Boobis AR. 2-Amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) induced mutations in cultured mammalian cells. Mutagenesis 1995; 10: 77-78.
41. Yadollahi-Farsani M, Gooderham NJ, Davies DS, Boobis AR. Mutational spectra of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) at the chinese hamster hprt locus. Carcinogenesis 1996; 17: 617-624.
42. Morgenthaler PM, Holzhäuser D. Analysis of mutations induced by 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) in human lymphoblastoid cells. Carcinogenesis 1995; 16: 713-718.
43. Chen RH, Maher VM, Brouwer J, Van de Putte P, McCormick JJ. Preferential repair and strand-specific repair of benzo[a]pyrene diol epoxide adducts in the hgprt gene of diploid human fibroblasts. Proc Natl Acad Sci USA 1992; 89: 5413-5417.
44. Ohgaki H, Takayama S, Sugimura T. Carcinogenicities of heterocyclic amines in cooked food. Mutat Res 1991; 259: 399-410.
45. Kato T, Ohgaki H, Hasegawa H, Sato S, Takayama S, Sugimura T. Induction of tumours in the Zymbal gland, oral cavity, colon, skin and mammary gland of F344 rats by a mutagenic compound 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Carcinogenesis 1988; 9: 71-73.
46. Ito N, Hasegawa R, Sano M, et al. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis 1991; 12: 1503-1506.
47. 1 mice by the food mutagen, 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine. Jpn J Cancer Res 1989; 80: 1176-1178.
48. Adamson RH, Snyderwine EG, Thorgeirsson SS, et al. Metabolic processing and carcinogenicity of heterocyclic amines in nonhuman primates. Int Symp Princess Takamatsu Cancer Research Fund 1990; 21: 289-301.
49. Edwards RJ, Murray BP, Murray S, et al. Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human. Carcinogenesis 1994; 15: 829-836.
50. Dooley KL, Von Tunglen LS, Bucci T, Fu PP, Kadlubar FF. Comparative carcinogencity of 4-aminobiphenyl and the food pyrolysates, Glu-P-1, IQ, PhIP, and MeIQx in the neonatal B6C3F1 male mouse. Cancer Lett 1992; 62: 205-209.
51. Rich KJ, Zhao K, Davies DS, Boobis AR, Gooderham NJ. Developmental changes in hepatic activation of 2-amino-3,8-dimethyl[4,5-f]quinoxaline in rabbit. Carcinogenesis 1996; 17: 555-558.
52. Kakiuchi H, Watanabe M, Ushijima T, et al. Specific 5′-GGGA-3′→5′-GGA-3′ mutation of the APC gene in rat colon tumours induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Proc Natl Acad Sci USA 1995; 92: 910-914.
53. Powell SM, Zilz N, Beazer-Barclay Y, et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992; 359: 235-237.
54. Gerhardsson de Verdier M, Hagman U, Peters RK, Steineck G, Overvick E. Meat, cooking methods and colorectal cancer: A case-referent study in Stockholm. Int J Cancer 1991; 49: 520-525.
55. Kadlubar FF, Butler MA, Kaderlik KR, Chou HC, Lang NP. Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis. Environ Health Perspect 1992; 98: 69-74.
56. Williams AC, Browne SJ, Manning AM, Hague A, van der Stappen JW, Paraskeva C. Biological consequences of the genetic changes which occur during human colorectal carcinogenesis. Semin Cancer Biol 1993; 4: 153-159.